Exact Sciences Corp (EXAS)
60.54
+0.53
(+0.88%)
USD |
NASDAQ |
May 02, 16:00
61.16
+0.62
(+1.02%)
After-Hours: 20:00
Exact Sciences Research and Development Expense (Quarterly): 114.92M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 114.92M |
| September 30, 2023 | 111.45M |
| June 30, 2023 | 104.10M |
| March 31, 2023 | 95.42M |
| December 31, 2022 | 94.27M |
| September 30, 2022 | 90.81M |
| June 30, 2022 | 106.08M |
| March 31, 2022 | 102.25M |
| December 31, 2021 | 88.49M |
| September 30, 2021 | 75.36M |
| June 30, 2021 | 106.24M |
| March 31, 2021 | 115.57M |
| December 31, 2020 | 446.40M |
| September 30, 2020 | 31.47M |
| June 30, 2020 | 32.67M |
| March 31, 2020 | 43.51M |
| December 31, 2019 | 43.22M |
| September 30, 2019 | 34.71M |
| June 30, 2019 | 29.97M |
| March 31, 2019 | 31.78M |
| December 31, 2018 | 20.01M |
| September 30, 2018 | 17.63M |
| June 30, 2018 | 14.71M |
| March 31, 2018 | 14.94M |
| December 31, 2017 | 12.64M |
| Date | Value |
|---|---|
| September 30, 2017 | 11.72M |
| June 30, 2017 | 9.737M |
| March 31, 2017 | 8.002M |
| December 31, 2016 | 7.082M |
| September 30, 2016 | 7.625M |
| June 30, 2016 | 8.64M |
| March 31, 2016 | 10.13M |
| December 31, 2015 | 9.365M |
| September 30, 2015 | 9.863M |
| June 30, 2015 | 8.115M |
| March 31, 2015 | 6.571M |
| December 31, 2014 | 4.992M |
| September 30, 2014 | 9.073M |
| June 30, 2014 | 7.174M |
| March 31, 2014 | 7.43M |
| December 31, 2013 | 6.713M |
| September 30, 2013 | 6.982M |
| June 30, 2013 | 6.457M |
| March 31, 2013 | 7.526M |
| December 31, 2012 | 10.44M |
| September 30, 2012 | 10.49M |
| June 30, 2012 | 12.20M |
| March 31, 2012 | 8.999M |
| December 31, 2011 | 7.672M |
| September 30, 2011 | 6.11M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
29.97M
Minimum
Jun 2019
446.40M
Maximum
Dec 2020
98.26M
Average
94.27M
Median
Dec 2022
Research and Development Expense (Quarterly) Benchmarks
| Illumina Inc | 341.00M |
| Guardant Health Inc | 89.86M |
| Natera Inc | 82.96M |
| Quest Diagnostics Inc | -- |
| Castle Biosciences Inc | 12.99M |